SoCalBio Boot Camp

SoCalBio Boot Camp for Emerging Companies 

Learn What it Takes to Build a Fundable and Viable Company

Offered Virtually
September 13,14, and15, 2021
From 1:00 PM to 5:00 PM (PDT) each day

Download Event Brochure Here!

This Boot Camp is offered by the SoCalBio Innovation Catalyst Program. It is designed for biotech, device, Dx and digital health companies. The Boot Camp will provide emerging entrepreneurs and innovators with an in-depth understanding of what it takes to raise earlystage capital and/or forge partnerships. Issues covered run the whole gamut from making effective presentations to negotiating term sheets.



Monday, September 13, 2021

1:00 PM

Welcoming remarks and acknowledgment of partners

  • Ahmed Enany, President & CEO, SoCalBio
  • Robert Greenberg, MD, PhD, Alfred Mann Foundation
1:10 PM

Overview of the 23rd Annual SoCalBio Conference on

Oct. 21-22, 2021 (To be held in-Person)

  • Proposed Agenda
  • Expectations Regarding Emerging Company Presentations
  • Platform for Setting up One-on-One Meetings
1:40 PMQ/A
2:00 PM

Crafting an Effective Pitch Deck in the Current Business   Environment


  • Steven Goldman, CEO, Geshtalti


  • Sasha Strauss, Managing Director, Innovation Protocol
  • Erik Deutsch, Principal, Excel PR Group
3:00 PMQ/A
3:15 PM

Hear an Investor Pitch That Secured Venture Funding

  • Robert Hamilton, PhD, Co-Founder & CSO, NovaSignal
3:30 PMQ/A
4:00 PMMeeting adjourns


Tuesday, September 14, 2021

1:00 PMIntroductory Remarks
1:05 PM

Understand the Risk Profile of your Venture and How it Impacts Financing


  • Parisa Khosropour, President, Khosropour Consulting


  • Michael Wise, Partner, Perkins Coie
  • William Dolphin, PhD, CEO, CueSquared
  • Evan Siegel, PhD, Ground Zero Pharmaceuticals
1:55 PMQ/A
2:10 PM

Planning your Fund-Raising Campaign. Where to Find the Money in Southern California and Elsewhere.

  • Ahmed Enany, President & CEO, SoCalBio
2:55 PMQ/A
3:00 PM

What’s its Worth? Understanding the Valuation of Early-Stage, Pre-Revenue Bioscience Firms in the Current Environment


  • David Hood, President, DH3 & Associates


  • CBIZ Valuation Group
  • Pankaj Singhal, PhD, President & CEO, NurtureX
3:50 PMQ/A
4:00 PM

What Is Involved in Negotiating Term Sheets


  • Winn Hong, Deputy Executive Director, AMI – USC


  • George Colindres, Partner, Perkins Coie
  • Thomas Stromberg, Partner, Perkins Coie
4:50 PMQ/A
5:00 PMMeeting adjourns


Wednesday, September 15, 2021

1:00 PMIntroductory remarks
1:05 PM

Making your Company Fundable. What Investors Look for?


  • Gary Lazar, MD, Biotech investor, and entrepreneur


  • Chris Bostick, PhD, VP, OCV Partners
  • Cristina Escoda, PhD, MBA, Founding Partner, Tachyon Ventures
  • Kwame Ulmer, Venture Partner, Wavemaker 360
  • Roger Zickfeld, Managing Director, Columbia Capital
1:55 PMQ/A
2:10 PM

Due Diligence Demystified: Angel, VC, and Strategic Approaches


  • AJ Bergman, CFO, Capricor Therapeutics
  • Matthew Pfeffer, Board Member, Second Sight Medical Products
  • Sunny Singh, President, Tech Coast Angels
2:50 PMQ/A
3:05 PM

Maximizing your Chances of Securing Angel, Strategic, and   Institutional Deals. Learn from Fellow Entrepreneurs.


  • Peter Blaisdell, PhD, Chair, SoCalBio Innovation Catalyst Program


  • Bruce Bauer, PhD, President & CEO, TAE Life Sciences
  • Bassil Dahiyat, PhD, President & CEO, Xencor Corp.
  • Frank Watanabe, PhD, CEO, Arcutis Biotherapeutics
3:55 PMQ/A
4:10 PMCompany Presentation Practice-Run
4:30 PMConcluding Remarks
4:45 PMMeeting adjourns